Celldex Therapeutics Inc (CLDX)
EBITDA Margin
-330004.55%
Quarterly · Period ending:
CLDX EBITDA Margin
Latest reported-330004.55%period ending
Latest reported-330004.55%period ending
CLDX Quarterly EBITDA Margin (100.00% → -330004.55%)
Quarterly ebitda margin
High-resolution chart · PNG
CLDX ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -676.6045% | |
| -483.2829% | |
| -1,602.122% | |
| -2,617.3489% | |
| -1,747.4334% | |
| -1,677.8934% | |
| 22,155.7576% | |
| -700% | |
| -216.9% | |
| -800% | |
| -172.7273% | |
| -525% | |
| -500% | |
| -350% | |
| -400% | |
| -2,000% | |
| -257.1429% | |
| -1,900% | |
| -866.6667% | |
| -2,100% | |
| -2,150% | |
| -350% | |
| -322.2222% | |
| -400% | |
| -208.3333% | |
| -208.3333% | |
| -200% | |
| -153.3333% | |
| -109.0909% | |
| -91.3043% | |
| -95.4545% | |
| -128.5714% | |
| -65.3846% | |
| -90.9091% | |
| -37.931% | |
| -58.3333% | |
| -70.8333% | |
| -16.2791% | |
| -111.7647% | |
| -94.1176% | |
| -44% | |
| -34.6154% | |
| -30.7692% | |
| -44% | |
| 5.8824% | |
| -2.8571% | |
| 100% | |
| 100% | |
| -308.6957% | |
| 100% | |
| 100% | |
| 100% | |
| -725% | |
| 100% | |
| 100% | |
| 100% | |
| -1,800% | |
| 100% | |
| 100% | |
| 100% | |
| 133.3333% | |
| 100% | |
| 100% |